Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer

American Journal of Hematology

Volumn 79, Issue 4, 2005, Pages 274-280

  Ota, Satoshi ^a   Wada, Hideo ^a   Nobori, Tsutomu ^a   Kobayashi, Toshihiko ^a   Nishio, Midori ^a   Nishioka, Yukiko ^a   Noda, Maki ^a   Sakaguchi, Akane ^a   Abe, Yasunori ^a   Nishioka, Junji ^a   Ishikura, Ken ^a   Yamada, Norikazu ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

D dimer; DVT; Negative predictive value (NPV); SFI

Indexed keywords

BIOCHEMICAL MARKER; D DIMER; FIBRIN; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; JAPAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ANGIOGRAPHY; DATA INTERPRETATION, STATISTICAL; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY EMBOLISM; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 23244466275     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20396     Document Type: Article

References (25)

1. Lehman CM, Wilson LW, Rodgers GM. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol 2004;122:178-184.
2. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 1998;24:293-297.
3. Minamikawa K, Wada H, Wakita Y, et al. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Thromb Haemost 1994;71:192-194.
4. Le Gal G, Bounameaux H. Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost 2004;2:1244-1246.
5. Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost 2004;2:1247-1255.
6. Linkins LA, Bates SM, Ginsberg JS, Kearon C. Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost 2004;2:1256-1260.
7. Tanigawa M, Wada H, Minamikawa K, et al. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Am J Hematol 1995;49:1-5.
8. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-1330.
9. Nieuwenhuizen W. A reference material for harmonization of D-dimer assays. Thromb Haemost 1997;77:1031-1033.
10. Dempfle CE, Zips S, Ergül H, Heene DL, FACT Study Group. The fibrin assay comparison trial (FACT). Thromb Haemost 2001;85:671-678.
11. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001;86:452-463.
12. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000;83:657-660.
13. Giuntini C, Di Ricco G, Marini C, Melillo E, Palla A. Pulmonary embolism: epidemiology. Chest 1995;107(Suppl 1):3S-9S.
14. Manganelli D, Palla A, Donnamaria V, Giuntini C. Clinical features of pulmonary embolism. Doubts and certainties. Chest 1995;107(Suppl 1):25S-32S.
15. Courtney DM, Kline JA. Identification of prearrest clinical factors associated with outpatient fatal pulmonary embolism. Acad Emerg Med 2001;8:1136-1142.
16. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003;349:1227-1235.
17. Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med 2003;349:1247-1255.
18. Wada H, Wakita Y, Nakase T, et al. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Am J Hematol 1996;51:255-260.
19. Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognizes the NH2-terminal conformation of fragment D. In: Matsuda M, Iwanaga S, Takada A, Henschen A, editors. Fibrinogen 4-Current basic and clinical aspects: proceedings of the International Fibrinogen Workshop, Kyoto, Japan, 27-28 August 1989. New York: Elsevier Science Publishing, Inc.; 1990. p 43-48.
20. Soe G, Kohno I, Inuzuka K, Itoh Y, Matsuda M. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma. Blood 1996;88:2109-2117.
21. Yamada N, Wada H, Nakase T, et al. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Blood Coagul Fibrinolysis 1995;6:627-633.
22. Wada H, Sakuragawa N, Shiku H. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. Semin Thromb Hemost 1998;24:294-297.
23. Wada H, Mori Y, Shimura M, et al. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. Am J Hematol 1998;58:189-194.
24. Wada H, Mori Y, Kaneko T, et al. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia. Am J Hematol 1993;44:112-116.
25. Kline JA, Wells PS. Methodology for a rapid protocol to rule out pulmonary embolism in the emergency department. Am Emerg Med 2003;42:266-275.